Favoni R - Search Results

1

Polysulfated heparinoids selectively inactivate heparin-binding angiogenesis factors.

Zugmaier G, Favoni R, Jaeger R, Rosen N, Knabbe C. Zugmaier G, et al. Among authors: favoni r. Ann N Y Acad Sci. 1999;886:243-8. doi: 10.1111/j.1749-6632.1999.tb09427.x. Ann N Y Acad Sci. 1999. PMID: 10667230

2

The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer.

Yee D, Rosen N, Favoni RE, Cullen KJ. Yee D, et al. Among authors: favoni re. Cancer Treat Res. 1991;53:93-106. doi: 10.1007/978-1-4615-3940-7_5. Cancer Treat Res. 1991. PMID: 1672092 Review.

3

Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor.

Yee D, Favoni RE, Lebovic GS, Lombana F, Powell DR, Reynolds CP, Rosen N. Yee D, et al. Among authors: favoni re. J Clin Invest. 1990 Dec;86(6):1806-14. doi: 10.1172/JCI114910. J Clin Invest. 1990. PMID: 2174908 Free PMC article.

4

Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer.

Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, Lippman ME, Rosen N. Yee D, et al. Among authors: favoni re. Mol Endocrinol. 1989 Mar;3(3):509-17. doi: 10.1210/mend-3-3-509. Mol Endocrinol. 1989. PMID: 2747657

5

Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.

Favoni RE, de Cupis A, Bruno S, Yee D, Ferrera A, Pirani P, Costa A, Decensi A. Favoni RE, et al. Br J Cancer. 1998 Jun;77(12):2138-47. doi: 10.1038/bjc.1998.358. Br J Cancer. 1998. PMID: 9649125 Free PMC article.

6

Responsiveness to hormone, growth factor and drug treatment of a human breast cancer cell line: comparison between early and late cultures.

de Cupis A, Pirani P, Fazzuoli L, Favoni RE. de Cupis A, et al. Among authors: favoni re. In Vitro Cell Dev Biol Anim. 1998 Nov-Dec;34(10):836-43. doi: 10.1007/s11626-998-0039-4. In Vitro Cell Dev Biol Anim. 1998. PMID: 9870534

7

Anti-insulin-like growth factor-I activity of a novel polysulphonated distamycin A derivative in human lung cancer cell lines.

de Cupis A, Ciomei M, Pirani P, Ferrera A, Ardizzoni A, Favoni RE. de Cupis A, et al. Among authors: favoni re. Br J Pharmacol. 1997 Feb;120(3):537-43. doi: 10.1038/sj.bjp.0700937. Br J Pharmacol. 1997. PMID: 9031761 Free PMC article.

8

The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach.

Favoni RE, de Cupis A. Favoni RE, et al. Pharmacol Rev. 2000 Jun;52(2):179-206. Pharmacol Rev. 2000. PMID: 10835099 Review.

9

Pre-clinical evaluation of new antineoplastic agents in NSCLC cell lines: evidence of histological subtype-dependent cytotoxicity.

Loprevite M, Favoni RE, de Cupis A, Pirani P, Merlo F, Grossi F, Ardizzoni A. Loprevite M, et al. Among authors: favoni re. Int J Oncol. 1999 Oct;15(4):787-92. doi: 10.3892/ijo.15.4.787. Int J Oncol. 1999. PMID: 10493963

10

Identification of insulin-like growth factor binding proteins in breast cancer cells.

Yee D, Favoni RE, Lippman ME, Powell DR. Yee D, et al. Among authors: favoni re. Breast Cancer Res Treat. 1991 Mar;18(1):3-10. doi: 10.1007/BF01975437. Breast Cancer Res Treat. 1991. PMID: 1713084

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters